Terran Biosciences
PrivateLast Round
Series B
Feb 1, 2024
Company Overview
Terran Biosciences is a biotechnology company that develops a platform for therapeutics and technologies for patients with neurological and psychiatric diseases.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terran Biosciences Comps
Public and private peers based on sector, stage, and business model.
Terran Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 1, 2024 | ||||
| Series B | Feb 1, 2024 |
Terran Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series B |
| Catalytic Impact Foundation | Series B |
| Noetic Fund | Series B |
| Astir Ventures | Series B |
| Transhuman Capital | Series B |
| Magna Filis | Series B |
| The Brkfst Club | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 3, 2026
Monthly visitors grew 33% MoM, reaching 1.7K.
- Jul 1, 2025
Monthly visitors increased 105% MoM, reaching 4.3K.
Terran Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Terran Biosciences's valuation, stock price, and market status.
Firmographic Details
HeadquartersNew York City, New York
Employee Range5
Year Founded2017
Last FundingFeb 1, 2024